WWW.JNEUROSCI.ORG
-
The Journal of Neuroscience
QUICK SEARCH:   [advanced]


     
-


HOME  |   SEARCH  |   ARCHIVE  |   SUBSCRIBE  |   CONTACT  |   HELP
This Article
Right arrow Full Text (PDF)
Right arrow Submit an eLetter
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (162)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Dumont, Y.
Right arrow Articles by Quirion, R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Dumont, Y.
Right arrow Articles by Quirion, R.

 Previous Article  |  Next Article 

Journal of Neuroscience, Vol 13, 73-86, Copyright © 1993 by Society for Neuroscience

ARTICLE

Comparative characterization and autoradiographic distribution of neuropeptide Y receptor subtypes in the rat brain

Y Dumont, A Fournier, S St-Pierre and R Quirion
Douglas Hospital Research Center, McGill University, Montreal, Quebec, Canada.

Some evidence has suggested the existence and differential distribution of neuropeptide Y (NPY) receptor subtypes in the mammalian brain (Dumont et al., 1990; Aicher et al., 1991). We now report on the extensive characterization and visualization of at least two classes of NPY receptor sites using a highly selective Y1 analog, [Leu31,Pro34]- NPY or [Pro34]-NPY, and a relatively specific Y2 competitor, NPY13-36. Autoradiographic studies using 125I-peptide YY (125I-PYY) clearly reveal that the Y1 receptor subtype is most abundant in various cortical areas, the dentate gyrus of the hippocampal formation, the claustrum, and the reuniens nucleus of the thalamus. In most other regions, 125I-PYY binding is potently inhibited by increasing concentrations of either NPY2-36 or NPY13-36, suggesting a Y2-like profile. Furthermore, binding assays using homogenates from discrete brain regions clearly demonstrate that various NPY fragments and analogs compete for 125I-PYY labeling with profiles indicative of heterogeneity of NPY receptor subtypes, even in the presence of a selective Y1 blocker. Thus, it is likely that, in addition to the Y1 receptor, which is particularly concentrated in cortical areas, the rat brain is enriched with a receptor class (Y2) that can exist under high- or low-affinity states or with additional receptor subtypes that are recognized by 125I-PYY. These findings cannot be explained by the existence of the very recently reported Y3 receptor subtype, since PYY does not possess significant affinity to this site (Grundemar et al., 1991). Further experiments are currently in progress to determine the nature and functional significance of each of these NPY/PYY receptor sites.


This article has been cited by other articles:


Home page
 Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
G. J. Hodges, D. N. Jackson, L. Mattar, J. M. Johnson, and J. K. Shoemaker
Neuropeptide Y and neurovascular control in skeletal muscle and skin
Am J Physiol Regulatory Integrative Comp Physiol, September 1, 2009; 297(3): R546 - R555.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
G. L. Rahardjo, X.-F. Huang, Y. Y. Tan, and C. Deng
Decreased Plasma Peptide YY Accompanied by Elevated Peptide YY and Y2 Receptor Binding Densities in the Medulla Oblongata of Diet-Induced Obese Mice
Endocrinology, October 1, 2007; 148(10): 4704 - 4710.
[Abstract] [Full Text] [PDF]

Home page
 J. Pharmacol. Exp. Ther.Home page
P. Bonaventure, D. Nepomuceno, C. Mazur, B. Lord, D. A. Rudolph, J. A. Jablonowski, N. I. Carruthers, and T. W. Lovenberg
Characterization of N-(1-Acetyl-2,3-dihydro-1H-indol-6-yl)-3-(3-cyano-phenyl)-N-[1-(2-cyclopentyl-ethyl)-piperidin-4yl]acrylamide (JNJ-5207787), a Small Molecule Antagonist of the Neuropeptide Y Y2 Receptor
J. Pharmacol. Exp. Ther., March 1, 2004; 308(3): 1130 - 1137.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
A. Bacci, J. R. Huguenard, and D. A. Prince
Differential modulation of synaptic transmission by neuropeptide Y in rat neocortical neurons
PNAS, December 24, 2002; 99(26): 17125 - 17130.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
J. C. Reubi, M. Gugger, B. Waser, and J.-C. Schaer
Y1-Mediated Effect of Neuropeptide Y in Cancer: Breast Carcinomas as Targets
Cancer Res., June 1, 2001; 61(11): 4636 - 4641.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
E. S. Corp, B. Greco, J. B. Powers, C. L. M. Bivens, and G. N. Wade
Neuropeptide Y inhibits estrous behavior and stimulates feeding via separate receptors in Syrian hamsters
Am J Physiol Regulatory Integrative Comp Physiol, April 1, 2001; 280(4): R1061 - R1068.
[Abstract] [Full Text] [PDF]

Home page
 J. Physiol.Home page
Q.-Q. Sun, J. R Huguenard, and D. A Prince
Neuropeptide Y receptors differentially modulate G-protein-activated inwardly rectifying K+ channels and high-voltage-activated Ca2+ channels in rat thalamic neurons
J. Physiol., February 15, 2001; 531(1): 67 - 79.
[Abstract] [Full Text] [PDF]

Home page
 J. Physiol.Home page
Q.-Q. Sun, G. Akk, J. R Huguenard, and D. A Prince
Differential regulation of GABA release and neuronal excitability mediated by neuropeptide Y1 and Y2 receptors in rat thalamic neurons
J. Physiol., February 15, 2001; 531(1): 81 - 94.
[Abstract] [Full Text] [PDF]

Home page
 J. Neurosci.Home page
K. A. Nichol, A. Morey, M. H. Couzens, J. Shine, H. Herzog, and A. M. Cunningham
Conservation of Expression of Neuropeptide Y5 Receptor between Human and Rat Hypothalamus and Limbic Regions Suggests an Integral Role in Central Neuroendocrine Control
J. Neurosci., December 1, 1999; 19(23): 10295 - 10304.
[Abstract] [Full Text] [PDF]

Home page
 Exp. Biol. Med.Home page
C. J. Phelps and D. L. Hurley
Pituitary Hormones as Neurotrophic Signals: Update on Hypothalamic Differentiation in Genetic Models of Altered Feedback
Experimental Biology and Medicine, October 2, 1999; 222(1): 39 - 58.
[Abstract] [Full Text]

Home page
 J. Neurosci.Home page
Y. Dumont, A. Fournier, and R. Quirion
Expression and Characterization of the Neuropeptide Y Y5 Receptor Subtype in the Rat Brain
J. Neurosci., August 1, 1998; 18(15): 5565 - 5574.
[Abstract] [Full Text] [PDF]

Home page
 J. Neurosci.Home page
J. Qian, W. F. Colmers, and P. Saggau
Inhibition of Synaptic Transmission by Neuropeptide Y in Rat Hippocampal Area CA1: Modulation of Presynaptic Ca2+ Entry
J. Neurosci., November 1, 1997; 17(21): 8169 - 8177.
[Abstract] [Full Text] [PDF]

Home page
 J. Neurophysiol.Home page
G. J. Klapstein and W. F. Colmers
Neuropeptide Y Suppresses Epileptiform Activity in Rat Hippocampus In Vitro
J Neurophysiol, September 1, 1997; 78(3): 1651 - 1661.
[Abstract] [Full Text] [PDF]

Home page
 J. Pharmacol. Exp. Ther.Home page
J. F. Tallman, R. J. Primus, R. Brodbeck, L. Cornfield, R. Meade, K. Woodruff, P. Ross, A. Thurkauf, and D. W. Gallager
I. NGD 94-1: Identification of a Novel, High-Affinity Antagonist at the Human Dopamine D4 Receptor
J. Pharmacol. Exp. Ther., August 1, 1997; 282(2): 1011 - 1019.
[Abstract] [Full Text]

Home page
 J. Biol. Chem.Home page
P. M. Rose, P. Fernandes, J. S. Lynch, S. T. Frazier, S. M. Fisher, K. Kodukula, B. Kienzle, and R. Seethala
Cloning and Functional Expression of a cDNA Encoding a Human Type 2 Neuropeptide Y Receptor
J. Biol. Chem., September 29, 1995; 270(39): 22661 - 22664.
[Abstract] [Full Text] [PDF]


-
-

Home  |   Search  |   Archive  |   Subscribe  |   Contact  |   Help
-
Copyright 2009 by Society for Neuroscience ONLINE ISSN: 1529-2401
-